Our Partners
Trending Now
Features
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
More
Medical Tourism
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
More
POPULAR NEWS
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
More
Biotechnology
MGM Healthcare’s Heart and Lung Transplant Team Performs an ABO-Incompatible Paediatric Heart Transplant on...
CHENNAI, August 23 , 2023 : MGM Healthcare is proud to announce the successful completion of an ABO-incompatible Paediatric Heart Transplant, crossing the blood...
IT & Software Support
Appointments
Syngene Appoints Dr. Mahesh Bhalgat as COO
Bengaluru, July 02, 2019: Syngene International Limited, a leading global Contract Research Organisation, today announced the appointment of Dr. Mahesh Bhalgat as Chief Operating Officer...
Awards
Columbia Asia Hospital Hebbal conferred with ‘Best Green Hospital Award’ under the Social Footprint...
Bengaluru, August 09, 2019: Columbia Asia Hospital Hebbal has been honoured with the 'Best Green Hospital Award' under Social Footprint category of the Express Healthcare Excellence...
Financial Results
Hester Biosciences Limited Q2 & H1 FY23 Results
Standalone revenue up by 27% and 6% for Q2 and H1 FY23
Consolidated revenue up by...
Jubilant Life Sciences – Q1’FY20 Results
Revenue at Rs. 2,182 Crore up 5% YoY; EBITDA at Rs 444 Crores down 1%...
Approvals
Lupin Receives Tentative Approval for Empagliflozin Tablets
Mumbai, August 04, 2020: Pharma major Lupin Limited (Lupin) announced that it has received tentative approval for its Empagliflozin Tablets, 10 mg and 25 mg,...
Clinical Trails
Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...
Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.
Bulk Drug
Health Care
Alternative Medicine
Eye Care
Dr Shroff’s Charity Eye Hospital and Standard Chartered, to host the 1st International Optometry...
New Delhi, December 29, 2023 : Dr Shroff’s Charity Eye Hospital together with Standard Chartered is organising India’s first International Optometry and Vision Science...
Dr Basu Eye Hospital organizes a Visionary Eye Health Camp at Modern Public School...
New Delhi, October 11, 2023 : Dr. Basu Eye Hospital organized an eye camp at Modern Public School , Shalimar Bagh, in anticipation of...
Product News
Adore the Luxury of Natural Skin and Hair Care Products
New Delhi, May 16, 2019: We all long for beautiful skin and hair but it's only possible with natural and herbal ingredients that have been...
Spotlight
SCHOTT Glass wins top awards at vendor meet organized by Borosil Klasspack
02:48
Indian Pharmaceutical Market forecast 2016-2026
00:16
Indian Pharmaceutical Industry has emerged as 3rd largest producer in the world Pharmacy College
07:27
Pharmaceuticals Industry in India 2015 - 2020
02:36
India Pharma Awards 2015
25:11
Aurobindo Pharma Corporate Film
13:14
Pharmaceutical Industry in India
03:14
Made In India-Pharmaceutical Industry-2015
09:19
Dr. Sunil Chandy Speaking on the topic Scaling up tertiary care in hinterland India
28:45
Phases of Pharmaceutical Industry
13:49
Latest News
Brain dead patient gives new lease of life to several patients
Bengaluru, October 12, 2023 : In yet another gesture of helping humanity, a 35-year-old -brain dead patient, Rangaswami (named changed) at SPARSH Hospital Rajarajeshwari...
Mental health plays a role in overall wellbeing – Follow these simple steps
By Dr.Pallavi Arvind Joshi, Consultant - Psychiatrist, Columbia Asia Hospital Whitefield
Do you all know that India has the highest rate of suicide among the...
HCG KLE Suchirayu Hospital Hubli treats 60-yr-old man suffering from CBD stone through the...
Hubli, January 02, 2024: HCG KLE Suchirayu Hospital, North Karnataka's leading multispecialty hospital, recently achieved a milestone in gastroenterology by successfully treating a 60-year-old man...
Dental Care
India’s leading dental chainoffers new year gift to crooked teeth patients – Clove InvisiBraces
Clove Dental has come up with special offers for its just launched invisible Aligners, a highly innovative alternative to existing metal braces
New Delhi, January...
Hospital Management
Drug Discovery & Development
Suppliers
Technology
Aster Hospitals Bangalore brings doctors to the home of patients via...
Aster Hospitals launch the “Aster eConsult” mobile application on both android and Apple store- The New Normal
Doctors across specialties to renowned surgeons...
Companies
Lupin launches Generic Seasonale® Tablets; receives FDA approval
Mumbai, Baltimore, October 25, 2012: – Pharma major, Lupin Ltd., announced today that its subsidiary Lupin Pharmaceuticals Inc. (collectively Lupin) has received final approval for its Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg from the United States Food and Drugs Administration (FDA) to market a generic version of Teva Branded Pharmaceuticals (Teva) Seasonale® Tablets (Levonorgestrel and Ethinyl Estradiol Tablets, USP), 0.15 mg/0.03 mg.
Lupin’s Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg are the AB-rated generic equivalent of Teva’s Seasonale® Tablets. Lupin’s Levonorgestrel and Ethinyl Estradiol tablets are a combined oral contraceptive indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Lupin is marketing its Levonorgestrel and Ethinyl Estradiol tablets in 84 pink active tablets each containing 0.15 mg of Levonorgestrel, a synthetic progestogen and 0.03 mg of Ethinyl estradiol, and 7 white inert tablets. Seasonale® Tablets had annual U.S sales of approximately USD 81.2 million (IMS MAT Jun 2012 sales).
Marketing
